RETRACTED: Prevalence and Profile of Hepatitis B Virus Infection among HIV-Infected Adults at Panzi Referral Hospital, in the Post-Conflict South Kivu Province, Eastern Democratic Republic of Congo

Parvine Basimane Bisimwa^1,2,3,4*, Dieudonné Bihehe Masemo^1,3, Andre Bulabula Nyandwe Hamama⁵, Théophile Kashosi Mitima^1,2, Aline Kusinza Byabène^1,3, Tony Akilimali Shindano⁶, Sioban Harlow², Jean Paulin Mbo Mukonkole^1,3, Narcisse Patrice Komas⁴, Jean Bisimwa Nachega^1,2,5,6,7,8

¹Université Evangéliqueen Afrique (UEA), Bukavu, Democratic Republic of Congo.
²International Center Advanced for Research and Training (ICART), Bukavu, Democratic Republic of Congo.
³Hopital Général de Référence de Panzi, Bukavu, Democratic Republic of Congo.
⁴Laboratoire des hépatites virales, Institut Pasteur de Bangui, Bangui, Central African Republic.
⁵Department of Medicine and Center for Infectious Diseases, Stellenbosch University, Cape Town, South Africa.
⁶Faculté de Médecine, Université Catholique de Bukavu (UCB), Bukavu, Democratic Republic of Congo.
⁷Department of Epidemiology, Infectious Diseases and Microbiology, University of Pittsburgh, Pennsylvania, USA.
⁸Department of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

DOI: 10.4236/wja.2019.93008                

Abstract

Short Retraction Notice 

The paper does not meet the standards of "World Journal of AIDS". This article has been retracted to straighten the academic record. In making this decision the Editorial Board follows COPE's Retraction Guidelines. The aim is to promote the circulation of scientific research by offering an ideal research publication platform with due consideration of internationally accepted standards on publication ethics. The Editorial Board would like to extend its sincere apologies for any inconvenience this retraction may have caused. 

Editor guiding this retraction: Prof. Linda D. Moneyham (EiC of WJA) Please see the article page for more details. 

The full retraction notice in PDF is preceding the original paper which is marked "RETRACTED".

Keywords

Democratic Republic of Congo, Hepatitis B Virus Infection, HIV-HBV Co-Infection, Prevalence

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1]	(2017) Monitoring and Evaluation for Viral Hepatitis B and C: Recommended Indicators and Framework. Technical Report, World Health Organization, Geneva. http://apps.who.int/iris/bitstream/10665/204790/1/9789241510288_eng.pdf
[2]	Ionita, G., Malviya, A., Rajbhandari, R., Schluter, W.W., Sharma, G., Kakchapati, S., Rijal, S. and Dixit, S. (2017) Seroprevalence of Hepatitis B Virus and Hepatitis C Virus Co-Infection among People Living with HIV/AIDS Visiting Antiretroviral Therapy Centres in Nepal: A First Nationally Representative Study. International Journal of Infectious Diseases, 60, 64-69. https://doi.org/10.1016/j.ijid.2017.04.011
[3]	Matthews, P.C., Geretti, A.M., Goulder, P.J.R. and Klenerman, P. (2014) Epidemiology and Impact of HIV Coinfection with Hepatitis B and Hepatitis C Viruses in Sub-Saharan Africa. Journal of Clinical Virology, 61, 20-33. https://doi.org/10.1016/j.jcv.2014.05.018
[4]	Hawkins, C., Christian, B., Ye, J., Nagu, T., Aris, E., Chalamilla, G., et al. (2013) Prevalence of Hepatitis B Co-Infection and Response to Antiretroviral Therapy among HIV-Infected Patients in Tanzania. AIDS, 276, 919-927. https://doi.org/10.1097/QAD.0b013e32835cb9c8
[5]	Wu, J.C., Huang, Y.H., Chau, G.Y., Su, C.W., Lai, C.R., Lee, P.C., et al. (2009) Risk Factors for Early and Late Recurrence in Hepatitis B-Related Hepatocellular Carcinoma. Journal of Hepatology, 51, 890-897. https://doi.org/10.1016/j.jhep.2009.07.009
[6]	Stabinski, L., O’Connor, S., Barnhart, M., Kahn, R.J. and Hamm, T.E. (2015) Prevalence of HIV and Hepatitis B Virus Co-Infection in Sub-Saharan Africa and the Potential Impact and Program Feasibility of Hepatitis B Surface Antigen Screening in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68, S274-S285.
[7]	Kabinda, J.M., Michèle, D.-W., Donnen, P., Miyanga, S.A. and Van den Ende, J. (2014) Factors for Viral Infection in Blood Donors of South Kivu in the Democratic Republic of Congo. Pan African Medical Journal, 19, 385. https://doi.org/10.11604/pamj.2014.19.385.4328
[8]	KabindaMaotela, J., Ramazani, S.Y., Misingi, P. and Dramaix-Wilmet, M. (2015) Blood Transfusion in the Democratic Republic of Congo: Efforts and Challenges. Médecine et Santé Tropicales, 25, 342-349.
[9]	Namululi, B.A., Guerrieri, C. and Dramaix, M. (2012) Impact of Method of Recruitment of Blood Donors on the Prevalence of HIV and HBV in Bukavu, DR Congo. Medicine et Santé Tropicales, 1, 69-74.
[10]	Batina, A., Kabemba, S. and Malengela, R. (2007) Marqueurs infectieux chez les donneurs de sang en République Démocratique du Congo (RDC). Revue Médicale de Bruxelles, 28, 145-149.
[11]	Kakisingi, C.N., Mukuku, O., Matanda, S.K., Manika, M.M., Kyabu, V.K., Kasamba, E.I., et al. (2016) Profil épidémiologique et séroprévalence des donneurs de sang aux cliniques universitaires de Lubumbashi, République Démocratique du Congo. Pan African Medical Journal, 23, 175. https://doi.org/10.11604/pamj.2016.23.175.8480
[12]	Kabinda, J.-M. and Katchunga, B.-P. (2010) Les hépatites virales B et C chez les porteurs du virus de l’immunodéficience humaine à Bukavu (Sud-Kivu), République démocratique du Congo. Journal Africain d’Hépato-Gastroentérologie, 4, 230-235. https://doi.org/10.1007/s12157-010-0204-8
[13]	Shindano, T.A., Kabinda, J.M., Mitashi, P. and Horsmans, Y. (2018) Hepatitis B Virus Infection in the Democratic Republic of Congo: A Systematic Review of Prevalence Studies (2000-2016). Journal of Public Health, 26, 595-603. https://doi.org/10.1007/s10389-018-0894-8
[14]	Day, S.L., Odem-Davis, K., Mandaliya, K.N., Jerome, K.R., Cook, L., et al. (2013) Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy. PLoS ONE, 8, e59346. https://doi.org/10.1371/journal.pone.0059346
[15]	Kfutwah, A.K., Tejiokem, M.C. and Njouom, R. (2012) A Low Proportion of HBeAg among HBsAg-Positive Pregnant Women with Known HIV Status Could Suggest Low Perinatal Transmission of HBV in Cameroon. Virology Journal, 9, 62. https://doi.org/10.1186/1743-422X-9-62
[16]	Wandeler, G., Musukuma, K., Zurcher, S., Vinikoor, M.J., Llenas-Garcia, J., Aly, M.M., et al. (2016) Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia. PLoS ONE, 11, e0152043. https://doi.org/10.1371/journal.pone.0152043
[17]	Ocama, P., Seremba, E., Apica, B. and Opio, K. (2015) Hepatitis B and HIV Co-Infection Is Still Treated Using Lamivudine Only Antiretroviral Therapy Combination in Uganda. African Health Sciences, 15, 328-333. https://doi.org/10.4314/ahs.v15i2.4
[18]	Laurent, C., Bourgeois, A., Mpoudi-Ngole, E., Kouanfack, C., Ciaffi, L., et al. (2010) High Rates of Active Hepatitis B and C Co-Infections in HIV-1 Infected Cameroonian Adults Initiating Antiretroviral Therapy. HIV Medicine, 11, 85-89. https://doi.org/10.1111/j.1468-1293.2009.00742.x
[19]	Zoufaly, A., Onyoh, E., Tih, P., Awasom, C. and Feldt, T. (2012) High Prevalence of Hepatitis B and Syphilis Co-Infections among HIV Patients Initiating Antiretroviral Therapy in the North-West Region of Cameroon. International Journal of STD & AIDS, 23, 435-438. https://doi.org/10.1258/ijsa.2011.011279
[20]	Sagoe, K.W., Agyei, A.A., Ziga, F., Lartey, M., et al. (2012) Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients with HIV Infection at a Major Treatment Centre in Ghana. Journal of Medical Virology, 84, 6-10. https://doi.org/10.1002/jmv.22262
[21]	Molu, J.P., Essome, M.C.N., Monamele, C.G. and Njouom, R. (2018) Sero-Prevalence of HBsAg in Naive HIV-Infected Patients in a Rural Locality of Cameroon. BMC Research Notes, 11, 39. https://doi.org/10.1186/s13104-018-3159-2
[22]	Kouanfack, C., Kowo, M., Haddison, E.S., Aletum, V.M., Takou, D., Awoumou, P., Tchokonte, S.C., Sosso, S., Oudou, N. and Torimiro, J.N. (2018) Undiagnosed Chronic Hepatitis B Infection and HIV Type 1 Drug Resistance Profile in AIDS Patients Receiving Tenofovir-Containing Antiretroviral Regimens: Considerations for Monitoring Resistant HIV Variants during Treatment. Microbiology Research Journal International, 23, 1-8. https://doi.org/10.9734/MRJI/2018/40801
[23]	Chambal, L.M., SamoGudo, E., Carimo, A., Corte Real, R., Mabunda, N., Maueia, C., et al. (2017) HBV Infection in Untreated HIV-Infected Adults in Maputo, Mozambique. PLoS ONE, 12, e0181836. https://doi.org/10.1371/journal.pone.0181836
[24]	Bivigou-Mboumba, B., Rouet, F., Mouinga-Ondeme, A., Deleplancque, L., Sica, J., Ndjoyi-Mbiguino, A., Njouom, R. and Francois-Souquière, S. (2017) Hepatitis B, C, and E Infection among HIV-Infected Patients in Franceville, Gabon: Retrospective Cross-Sectional Study. Médecine et Santé Tropicales, 27, 274-280.
[25]	Agyeman, A.A. and Ofori-Asenso, R. (2016) Prevalence of HIV and Hepatitis B Coinfection in Ghana: A Systematic Review and Meta-Analysis. AIDS Research and Therapy, 13, 23. https://doi.org/10.1186/s12981-016-0107-x
[26]	Geretti, A.M., Patel, M., Sarfo, F.S., Chadwick, D., Verheyen, J., Fraune, M., Garcia, A. and Phillips, R.O. (2010) Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in Ghana. Journal of Clinical Microbiology, 48, 3223-3230. https://doi.org/10.1128/JCM.02231-09
[27]	Hoffmann, C.J., Charalambous, S., Martin, D.J., Innes, C., Churchyard, G.J., Chaisson, R.E., Grant, A.D., Fielding, K.L. and Thio, C.L. (2008) Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program. Clinical Infectious Diseases, 47, 1479-1485. https://doi.org/10.1086/593104
[28]	Dovonou, C.A., Amidou, S.A., Kpangon, A.A., Traore, Y.A., Godjedo, T.P., Satondji, A.J., et al. (2015) Prevalence of Hepatitis B in People Infected with HIV in Parakou in Benin. Pan African Medical Journal, 20, 125. https://doi.org/10.11604/pamj.2015.20.125.6061
[29]	Rusine, J., Ondoa, P., Asiimwe-Kateera, B., Boer, K.R., Uwimana, J.M., et al. (2013) High Seroprevalence of HBV and HCV Infection in HIV-Infected Adults in Kigali, Rwanda. PLoS ONE, 8, e63303. https://doi.org/10.1371/journal.pone.0063303
[30]	Barth, R.E., Huijgen, Q., Taljaard, J. and Hoepelman, A.I. (2010) Hepatitis B/C and HIV in Sub-Saharan Africa: An Association between Highly Prevalent Infectious Diseases. A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, 14, e1024-e1031. https://doi.org/10.1016/j.ijid.2010.06.013
[31]	Diwe, C.K., Okwara, E.C., Enwere, O.O., Azike, J.E. and Nwaimo, N.C. (2013) Sero-Prevalence of Hepatitis B Virus and Hepatitis C Virus among HIV Patients in a Suburban University Teaching Hospital in South-East Nigeria. Pan African Medical Journal, 16, 7. https://doi.org/10.11604/pamj.2013.16.7.3077
[32]	Pirillo, M.F., Bassani, L., Germinario, E.A., Mancini, M.G., Vyankandondera, J., et al. (2007) Seroprevalence of Hepatitis B and C Viruses among HIV-Infected Pregnant Women in Uganda and Rwanda. Journal of Medical Virology, 79, 1797-1801. https://doi.org/10.1002/jmv.21007
[33]	Masarone, M., De Renzo, A., La Mura, V., et al. (2014) Management of the HBV Reactivation in Isolated HBcAb Positive Patients Affected with Non Hodgkin Lymphoma. BMC Gastroenterology, 14, 31. https://doi.org/10.1186/1471-230X-14-31
[34]	Neau, D., Winnock, M., Galperine, T., et al. (2004) Isolated Antibodies against the Core Antigen of Hepatitis B Virus in HIV-Infected Patients. HIV Medicine, 5, 171-173. https://doi.org/10.1111/j.1468-1293.2004.00206.x
[35]	Landrum, M.L., Roediger, M.P., Fieberg, A.M., et al. (2011) Development of Chronic Hepatitis B Virus Infection in Hepatitis B Surface Antigen Negative HIV/HBV Co-Infected Adults: A Rare Opportunistic Illness. Journal of Medical Virology, 83, 1537-1543. https://doi.org/10.1002/jmv.22155
[36]	Majzoobi, M.M., Mamani, M., Hashemi, S.H., et al. (2018) Isolated Hepatitis B Core Antibody in HIV Infected Patients—Can Response to Hepatitis B Vaccine Help to Elucidate the Cause? Caspian Journal of Internal Medicine, 9, 328-333.
[37]	Liang, S.H., Chen, T.J., Lee, S.S., et al. (2010) Risk Factors of Isolated Antibody against Core Antigen of Hepatitis B Virus: Association with HIV Infection and Age But Not Hepatitis C Virus Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54, 122-128. https://doi.org/10.1097/QAI.0b013e3181daafd5
[38]	Nebbia, G., Garcia-Diaz, A., Ayliffe, U., Smith, C., Dervisevic, S., et al. (2007) Predictors and Kinetics of Occult Hepatitis B Virus Infection in HIV-Infected Persons. Journal of Medical Virology, 79, 1464-1471. https://doi.org/10.1002/jmv.20954
[39]	Shire, N.J., Rouster, S.D., Rajici, N. and Sherman, K.E. (2004) Occult Hepatitis B in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 36, 869-875. https://doi.org/10.1097/00126334-200407010-00015
[40]	Chadwick, D., Stanley, A., Sarfo, S., Appiah, L., Ankcorn, M., et al. (2013) Response to Antiretroviral Therapy in Occult Hepatitis B and HIV Co-Infection in West Africa. AIDS, 27, 139-141. https://doi.org/10.1097/QAD.0b013e3283589879
[41]	Firnhaber, C., Viana, R., Reyneke, A., Schultze, D., Malope, B., et al. (2009) Occult Hepatitis B Virus Infection in Patients with Isolated Core Antibody and HIV Coinfection in an Urban Clinic in Johannesburg, South Africa. International Journal of Infectious Diseases, 13, 488-492. https://doi.org/10.1016/j.ijid.2008.08.018
[42]	Lewin, S.R., Ribeiro, R.M., Avihingsanon, A., Bowden, S., Matthews, G., Marks, P., Locarnini, S.A., Ruxrungtham, K., Perelson, A.S. and Dore, G.J. (2009) Viral Dynamics of Hepatitis B Virus DNA in Human Immunodeficiency Virus-1-Hepatitis B Virus Coinfected Individuals: Similar Effectiveness of Lamivudine, Tenofovir, or Combination Therapy. Hepatology, 49, 1113-1121. https://doi.org/10.1002/hep.22754
[43]	Boyd, A., Gozlan, J., Miailhes, P., Lascoux-Combe, C., Cam, M.S., Rougier, H., et al. (2015) Rates and Determinants of Hepatitis B “e” Antigen and Hepatitis B Surface Antigen Seroclearance during Long-Term Follow-Up of Patients Coinfected with HIV and Hepatitis B Virus. AIDS, 29, 1963-1973. https://doi.org/10.1097/QAD.0000000000000795
[44]	De Vries-Sluijs, T.E., Reijnders, J.G., Hansen, B.E., Zaaijer, H.L., Prins, J.M., Pas, S.D., et al. (2010) Long-Term Therapy with Tenofovir Is Effective for Patients Co-Infected with Human Immunodeficiency Virus and Hepatitis B Virus. Gastroenterology, 139, 1934-1941. https://doi.org/10.1053/j.gastro.2010.08.045
[45]	Domaoal, R.A., McMahon, M., Thio, C.L., Bailey, C.M., Tirado-Rives, J., Obikhod, A., et al. (2008) Pre-Steady-State Kinetic Studies Establish Entecavir 5’-Triphosphate as a Substrate for HIV-1 Reverse Transcriptase. The Journal of Biological Chemistry, 283, 5452-5459. https://doi.org/10.1074/jbc.M707834200
[46]	Doranz, B.J., Berson, J.F., Rucker, J. and Doms, R.W. (1997) Chemokine Receptors as Fusion Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1). Immunologic Research, 16, 15-28. https://doi.org/10.1007/BF02786321
[47]	Sinicco, A., Raiteri, R., Sciandra, M., Bertone, C., Lingua, A., Salassa, B., et al. (1997) Coinfection and Superinfection of Hepatitis B Virus in Patients Infected with Human Immunodeficiency Virus: No Evidence of Faster Progression to AIDS. Scandinavian Journal of Infectious Diseases, 29, 111-115. https://doi.org/10.3109/00365549709035869